The company's Ariogen Pharmaceutical Biotechnology Research Center was established in 2012 to produce recombinant drugs and collaborate with academia and renowned universities and institutes. AryoGen Pharmed provides various biopharmaceuticals to the market and has a strong commitment to improving global health.